RHOC and breast carcinoma: Research on breast cancer has reported that interfering with RhoC gene expression could inhibit the proliferation and infiltration abilities of tumor cells through a mechanism that likely involves the simultaneous downregulation of matrix metalloproteinase‐9 (MMP‐9).25 The ECM primarily exists between cells, and therefore, angiogenesis requires the degradation of the ECM.